Effect of Heatwave Over Glycemic Control in Patients With T1D
Launched by CASTILLA-LA MANCHA HEALTH SERVICE · Dec 2, 2022
Trial Information
Current as of July 03, 2025
Completed
Keywords
ClinConnect Summary
Cross-sectional retrospective analysis of all patients with T1D in Castilla-La Mancha (south-central Spanish region) using intermittently scanned continuous glucose monitoring (isCGM). Glycometric data obtained through deidentified downloads from isCGM´s webpage. Primary outcome was time in range (TIR) 3.0-10 mmol/L (70-180 mg/d) change after the heatwave. Data analysis is conducted using SPSS (Chicago, IL) statistics software. Results are presented as mean ± SD values or percentages. A paired Student's t-test or a Wilcoxon signed-rank test were used for the analysis of differences. Compari...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Type 1 diabetes
- • Older than 18 years old
- • Using intermittently scanned continuous glucose monitoring (isCGM)
- • Paired active isCGM data from the heatwave period and two consecutive weeks
- Exclusion Criteria:
- • Younger than 18 years old
- • Not using intermittently scanned continuous glucose monitoring
- • Not having active paired isCGM data from the analyzed periods
About Castilla La Mancha Health Service
The Castilla-La Mancha Health Service (Servicio de Salud de Castilla-La Mancha, SESCAM) is a regional healthcare authority in Spain dedicated to providing high-quality medical services and advancing public health. As a clinical trial sponsor, SESCAM plays a pivotal role in facilitating innovative research initiatives aimed at improving patient outcomes and enhancing medical practices. The organization is committed to ethical standards, regulatory compliance, and collaboration with various stakeholders, including healthcare professionals, researchers, and pharmaceutical companies, to foster the development of new therapies and interventions that address pressing health challenges in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ciudad Real, , Spain
Valdepeñas, Ciudad Real, Spain
Puertollano, Ciudad Real, Spain
Talavera De La Reina, Toledo, Spain
Albacete, , Spain
Guadalajara, , Spain
Toledo, , Spain
Alcázar De San Juan, Ciudad Real, Spain
Cuenca, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials